院内呼吸道病毒感染 (NOSOVIRUS)
医院获得性呼吸道病毒感染:法国的一项前瞻性多中心研究
Hospital-acquired Viral Respiratory Infections (HAVRI) are associated with substantial burden on health care systems. The prevention and control of these viral infections rely on multiple measures such as hand hygiene or wearing mask. However, vaccination remains the major preventive measure.
To date, data at French national level are insufficient to describe the epidemiology of these infections, including their burden, and the potential protection of patients if vaccination coverage of health care professionals/patients is satisfactory. In addition, better understanding of the clinical characteristics of HAVRI will make it possible to identify potential sources of transmission as soon as possible and to implement appropriate hygiene measures.
We will set up a hospital-based prospective multicenter study in Bordeaux, Paris-Bichat, Dijon and Lyon, involving four inclusion services (geriatrics, internal medicine and transplantation) per hospital.
The main objective of this study is to calculate the incidence rate of hospital-acquired infections for three respiratory viruses; influenza, SARS-CoV-2 and syncytial respiratory virus (SRV), referred to as HARVI, in participating services.
Volunteered health care professionals or hospitalized patients presenting with influenza-like illness (ILI) at admission or during their stay in the participating centers will be eligible to be enrolled during the two inclusion periods: (mid-October 2024 to mid-April 2025 and mid-October 2025 to mid-April 2026).
For each patient/health care professional, a nasopharyngeal swab will be collected. A questionnaire including demographic data, medical history, vaccination, and clinical and biological data of the viral episode will also be completed by the study team. Patients tested positive for one of the viruses studied will be considered "cases" and patients tested negative as "controls".
The collected data will be pseudonymized before statistical analyses. Statistical analyses will consist of calculating incidence rates, attack rates overall and by causative virus and analysis of factors associated with the occurrence of HARVI.
The prospective design of the study will optimize the quality of the collected data (ex. consolidate the documentation of both the clinical picture and vaccination in patients and health care professionals by reducing memory bias) and allow to calculate the incidence rates, the crude and adjusted relative risks of HARVI according to the studied factors, and to describe multiple outcomes (hospitalization in intensive care units, death, etc.) based on the causative virus.
The results of this research project will allow to:
- obtain epidemiological indicators associated with HARVI;
- estimate the impact of HARVI on the prognosis of patients in hospital;
- assess the impact of HARVI on the total length of hospital stay;
- identify risk factors associated with HARVI;
- use the results as an argument for vaccination in order to increase vaccination coverage of healthcare workers.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Philippe VANHEMS, MD, PhD
- 电话号码:+33 4 72 11 07 20
- 邮箱:Philippe.vanhems@chu-lyon.fr
研究联系人备份
- 姓名:Mitra SAADATIAN-ELAHI
- 电话号码:+33 4 72 11 07 18
- 邮箱:Mitra.elahi@chu-lyon.fr
学习地点
-
-
-
Bordeaux、法国、33076
- 尚未招聘
- Pellegrin Hospital
-
接触:
- Anne Marie ROGUES, Professor
- 电话号码:+33 5 56 79 55 53
- 邮箱:anne-marie.rogues@chu-bordeaux.fr
-
首席研究员:
- Anne Marie ROGUES, Professor
-
Dijon、法国、21079
- 尚未招聘
- CHU Dijon
-
接触:
- Ludwig Serge AHO-GLELE, Professor
- 电话号码:+33 3 80 29 38 01
- 邮箱:ludwig.aho@chu-dijon.fr
-
首席研究员:
- Ludwig Serge AHO-GLELE, professor
-
Lyon、法国、69003
- 招聘中
- Edouard Herriot Hospital
-
接触:
- Philippe VANHEMS, Professor
- 电话号码:+33 4 72 11 07 20
- 邮箱:Philippe.vanhems@chu-lyon.fr
-
首席研究员:
- Philippe VANHEMS, Professor
-
Paris、法国
- 尚未招聘
- Saint Louis Hospital
-
接触:
- Nathalie DE CASTRO, Dr
- 电话号码:01 42 49 48 20
- 邮箱:nathalie.de-castro@aphp.fr
-
Paris、法国、75877
- 尚未招聘
- Bichat Hospital
-
接触:
- Solen KERNEIS, Professor
- 电话号码:+33 1 40 25 60 59
- 邮箱:solen.kerneis@aphp.fr
-
首席研究员:
- Solen KERNEIS, professor
-
Paris、法国、75010
- 尚未招聘
- Saint Louis Hospital
-
接触:
- Guillaume MELLON, Dr
- 电话号码:01 42 49 44 97
- 邮箱:guillaume.mellon@aphp.fr
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adults> 18 years old
- Hospitalized patient or health care professionals presenting an ILI on admission or during the stay, meeting the following definition: fever greater than 37.8° C in the absence of taking antipyretics and/or cough or pharyngeal pain.
- Signed consent form
Exclusion Criteria:
- Pregnant, parturient or breastfeeding women
- individuals deprived of their liberty by a judicial or administrative decision
- Individuals subject to psychiatric care
- Individuals admitted to a health or social establishment for purposes other than research
- Individuals under a legal protection measure (guardianship, curatorship)
- Individuals not affiliated to a social security insurance
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:非随机化
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
其他:Patients hospitalized in participating services for more than 24h
Patients hospitalized for more than 24 hours in the participating services (geriatric, internal medicine, transplantation) and who presents an influenza like illness (ILI) on admission or during hospital stay are eligible to participate. Following the signature of the consent, nasopharyngeal sample will be collected. Socio-demographic (questionnaire) and clinical information will be obtained using the study e-CRF. |
Nasopharyngeal swab collection will be carried out in patients and health care professionals presenting an ILI during the study period. This will be done by trained clinical research associates after the signature of the consent. Only one nasopharyngeal sample is expected to be collected from each participant. questionnaire including demographic data, data on medical history and vaccination, and clinical and biological data on the viral episode. |
|
其他:Volunteered health care professionals
Volunteered health care professionals in the participating services (geriatric, internal medicine, transplantation) and who presents an influenza like illness (ILI) are eligible to participate. Following the signature of the consent, nasopharyngeal sample will be collected. Socio-demographic (questionnaire) and clinical information will be obtained using the study e-CRF |
Nasopharyngeal swab collection will be carried out in patients and health care professionals presenting an ILI during the study period. This will be done by trained clinical research associates after the signature of the consent. Only one nasopharyngeal sample is expected to be collected from each participant. questionnaire including demographic data, data on medical history and vaccination, and clinical and biological data on the viral episode. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of hospital-acquired respiratory viral infections
大体时间:At inclusion
|
The primary endpoint will be evaluated by calculating the incidence of hospital-acquired respiratory viral infections overall and by type of virus (influenza, COVID-19, RSV) during the surveillance period. incidence rate will be estimated by the ration of number of incident cases over the study period to the cumulative observation time (in person-weeks) of hospitalized patients. Incidence density will be estimated by the ratio of number of incident cases during successive weekly observation periods to the cumulative observation times calculated over the same periods. |
At inclusion
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 69HCL23_1091
- 2024-A01267-40 (其他标识符:ID-RCB)
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.